anthralin has been researched along with transforming growth factor alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashinoff, R; Gottlieb, AB; Khandke, L; Krane, JF; Krueger, JG; Staiano-Coico, L | 1 |
| Akhurst, RJ; Mackie, RM; Stables, GS; Watts, P | 1 |
2 other study(ies) available for anthralin and transforming growth factor alpha
| Article | Year |
|---|---|
Anthralin decreases keratinocyte TGF-alpha expression and EGF-receptor binding in vitro.
Topics: Anthralin; Cell Division; ErbB Receptors; Humans; Insulin-Like Growth Factor I; Keratinocytes; Psoriasis; Receptors, Cell Surface; Receptors, Somatomedin; Transforming Growth Factor alpha | 1992 |
Localization of transforming growth factor-alpha RNA and protein in the skin of psoriatic patients receiving therapy.
Topics: Anthralin; Coal Tar; Epidermis; Etretinate; Gene Expression; Humans; Immunohistochemistry; In Situ Hybridization; Psoriasis; PUVA Therapy; RNA; Steroids; Transforming Growth Factor alpha; Ultraviolet Therapy | 1994 |